These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2408290)

  • 1. Serotonin and schizophrenia: correlations between serotonergic activity and schizophrenic motor behavior.
    King R; Faull KF; Stahl SM; Mefford IN; Thiemann S; Barchas JD; Berger PA
    Psychiatry Res; 1985 Mar; 14(3):235-40. PubMed ID: 2408290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet serotonin concentration and depressive symptoms in patients with schizophrenia.
    Peitl V; Vidrih B; Karlović Z; Getaldić B; Peitl M; Karlović D
    Psychiatry Res; 2016 May; 239():105-10. PubMed ID: 27137969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative uptake study of serotonin, dopamine, and norepinephrine by platelets of acute schizophrenic patients.
    Rotman A; Munitz H; Modai I; Tjano S; Wijsenbeek H
    Psychiatry Res; 1980 Dec; 3(3):239-46. PubMed ID: 6110216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia.
    Jakovljević M; Mück-Seler D; Pivac N; Ljubicić D; Bujas M; Dodig G
    Biol Psychiatry; 1997 May; 41(10):1028-34. PubMed ID: 9129783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
    Pivac N; Mück-Seler D; Jakovljević M
    Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin in violent patients with schizophrenia.
    Kunz M; Sikora J; Krakowski M; Convit A; Cooper TB; Volavka J
    Psychiatry Res; 1995 Nov; 59(1-2):161-3. PubMed ID: 8771232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.
    Jackman H; Luchins D; Meltzer HY
    Biol Psychiatry; 1983 Aug; 18(8):887-902. PubMed ID: 6615945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered platelet serotonin uptake kinetics in schizophrenia and depression.
    Kaplan RD; Mann JJ
    Life Sci; 1982 Aug; 31(6):583-8. PubMed ID: 7132568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on platelet 5-HT concentrations in healthy controls, depressed and schizophrenic patients.
    Mück-Seler D; Bujas M; Ljubić-Thibal V; Jakovljević M
    Neuropsychobiology; 1996; 34(4):201-3. PubMed ID: 9121621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients.
    Joseph MH; Owen F; Baker HF; Bourne RC
    Psychol Med; 1977 Feb; 7(1):159-62. PubMed ID: 859953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive behaviors in chronically institutionalized schizophrenic patients.
    Luchins DJ; Goldman MB; Lieb M; Hanrahan P
    Schizophr Res; 1992 Dec; 8(2):119-23. PubMed ID: 1457389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia.
    Berk M; Plein H; Csizmadia T
    Int Clin Psychopharmacol; 1999 Mar; 14(2):119-22. PubMed ID: 10220127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
    Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristics.
    Csernansky JG; King RJ; Faustman WO; Moses JA; Poscher ME; Faull KF
    Br J Psychiatry; 1990 Apr; 156():501-7. PubMed ID: 1696842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet membrane lysophosphatidylcholine in schizophrenia.
    Pangerl AM; Steudle A; Jaroni HW; Rüfer R; Gattaz WF
    Biol Psychiatry; 1991 Oct; 30(8):837-40. PubMed ID: 1751626
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
    Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M
    Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the concentration of 5-hydroxyindoleacetic acid in schizophrenia: a meta-analysis.
    Tuckwell HC; Koziol JA
    Psychiatry Res; 1996 Jan; 59(3):239-44. PubMed ID: 8930029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
    Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
    Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia.
    Ljubicić D; Stipcević T; Pivac N; Jakovljević M; Mück-Seler D
    J Photochem Photobiol B; 2007 Dec; 89(2-3):63-9. PubMed ID: 17937992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D; Breier A; Hsiao JK; Doran AR; Wolkowitz OM; Pato CN; Konicki PE; Potter WZ
    Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.